Search: Organigram

Organigram Q2 Revenue Slides 24% Sequentially to C$14.6 Million

Organigram Reports Second Quarter Fiscal 2021 Results Launched 62 new stock-keeping units (SKUs) since July 2020 as part of the Company’s product portfolio revitalization; up to 31 more SKUs expected to launch by the end of Q3 2021 SHRED was the #1 most-searched brand on the Ontario Cannabis Store website for the last 5 consecutive […] READ MORE: https://www.newcannabisventures.com/organigram-q2-revenue-declines-24-sequentially-to-14-6-million/

Organigram Reports Second Quarter Fiscal 2021 Results

MONCTON, New Brunswick–(BUSINESS WIRE)—- $OGI–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2021 (“Q2 2021”). “Although Q2 2021 results were challenged by industry dynamics, COVID-19 and staffing limitations at our facility, we believe there…

Organigram Acquires Soft Chew Manufacturer: Edibles & Infusions Corporation, a Cannabis Processor Backed by Decades of Confectionary Experience

MONCTON, New Brunswick–(BUSINESS WIRE)—- $OGI–Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (together with OGI, “Organigram” or the “Company”), a leading producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of The Edibles & Infusions Corporation (“EIC”) (the “EIC Acquisition”) for consideration of $22.0 million,…

Organigram to Report Second Quarter Fiscal 2021 Results on April 13, 2021

MONCTON, New Brunswick–(BUSINESS WIRE)—- $OGI–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ended February 28, 2021 on Tuesday April 13, 2021 before market open. The Company will host a conference call to…

Moncton cannabis ‘centre of excellence’ to result from $221M Organigram stock deal

A centre of excellence focused on developing new cannabis products is planned in Moncton as part of a tobacco company’s purchase of a nearly 20 per cent stake in Organigram. Organigram announced Thursday that the centre of excellence, focused on “developing the next generation of cannabis products with an initial focus on CBD,” will be located at the company’s indoor facility in Moncton.…

Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity Interest

MONCTON, New Brunswick–(BUSINESS WIRE)—- $OGI–Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI) is pleased to announce a C$221 million strategic investment from a wholly-owned subsidiary of BAT (LSE:BATS and NYSE:BTI). The BAT subsidiary has subscribed for approximately 58.3 million common shares of OGI, which represents a 19.9% equity interest1 on a post-transaction basis for total proceeds of approximately C$221…

Organigram Q1 Revenue Slips 5% Sequentially to C$19.3 Million

Organigram Reports First Quarter Fiscal 2021 Results Q1 2021 Canadian adult-use recreational gross and net revenue grew 42% and 30%, respectively, to $22.5 million and $16.8 million, respectively, from Q1 2020 Q1 2021 Canadian adult-use recreational gross and net revenue grew sequentially 14% and 11%, respectively, from Q4 2020 Generated positive cash flow from operations […] READ MORE: https://www.newcannabisventures.com/organigram-q1-revenue-slips-5-sequentially-to-c19-3-million/

Organigram Reports First Quarter Fiscal 2021 Results

MONCTON, New Brunswick–(BUSINESS WIRE)—- $OGI–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2020 (“Q1 Fiscal 2021” or “Q1 2021”). Select Key Financial Metrics (in $000s) unless otherwise indicated Q1 2021 Q1 2020 % Change…